Insider · CIK 0001801061

Watanabe Todd

Reports to the SEC for 1 company · WESTLAKE VILLAGE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001801061

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−4,375 sh	$26.12	−$114K	717,203
2026-05-04	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−3,172 sh	$23.61	−$74.9K	720,755
2026-03-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−36.3K sh	$25.16	−$913K	787,025
2026-03-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−1,068 sh	$25.91	−$27.7K	785,957
2026-02-27	ARQTArcutis Biotherapeutics, Inc.A Award	Director, See Remarks	AAward	+102K sh	—	—	823,306
2026-02-27	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+266K sh	—	—	266,000
2026-02-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−19.8K sh	$25.50	−$506K	721,306
2025-11-24	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−48.9K sh	$30.36	−$1.49M	740,537
2025-11-21	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−1,055 sh	$30.00	−$31.7K	793,838
2025-11-03	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−11.5K sh	$24.71	−$284K	794,962
2025-11-03	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−69 sh	$25.40	−$1,752.538	794,893
2025-10-28	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−40K sh	$25.03	−$1M	806,440
2025-10-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−20.7K sh	$20.04	−$416K	846,440
2025-10-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−15K sh	$18.91	−$284K	876,440
2025-10-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−9,261 sh	$20.02	−$185K	867,179
2025-09-09	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−504 sh	$17.52	−$8,829.022	891,440
2025-09-08	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−9,625 sh	$17.54	−$169K	891,944
2025-08-04	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−11.5K sh	$14.33	−$165K	901,569
2025-06-10	ARQTArcutis Biotherapeutics, Inc.G Gift	Director, See Remarks	GGift	−997 sh	—	—	914,113
2025-06-10	ARQTArcutis Biotherapeutics, Inc.G Gift	Director, See Remarks	GGift	+997 sh	—	—	25,410
2025-06-10	ARQTArcutis Biotherapeutics, Inc.G Gift	Director, See Remarks	GGift	−997 sh	—	—	913,116
2025-06-10	ARQTArcutis Biotherapeutics, Inc.G Gift	Director, See Remarks	GGift	+997 sh	—	—	25,410
2025-05-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−11.4K sh	$15.19	−$174K	913,795
2025-03-25	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−2,171 sh	$17.56	−$38.1K	925,243
2025-03-24	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−1,500 sh	$17.52	−$26.3K	927,414
2025-03-17	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−1,200 sh	$17.61	−$21.1K	928,914
2025-03-04	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−4,135 sh	$13.28	−$54.9K	930,114
2025-03-03	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−20.9K sh	$13.03	−$272K	934,249
2025-02-28	ARQTArcutis Biotherapeutics, Inc.A Award	Director, See Remarks	AAward	+151K sh	—	—	955,129
2025-02-28	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+396K sh	—	—	396,000
2025-02-03	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−19.3K sh	$12.70	−$245K	804,129
2024-12-20	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−15K sh	$15.17	−$228K	823,430
2024-11-30	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+2,038 sh	$7.11	+$14.5K	838,430
2024-11-04	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−13.9K sh	$8.68	−$120K	832,392
2024-08-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−14.5K sh	$9.02	−$131K	846,263
2024-05-31	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director, See Remarks	PPurchase	+4,000 sh	$1.69	+$6,768	836,392
2024-05-02	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−13.8K sh	$8.74	−$120K	860,750
2024-03-04	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−14.9K sh	$11.12	−$166K	874,533
2024-02-28	ARQTArcutis Biotherapeutics, Inc.S Sale	Director, See Remarks	SSale	−2,465 sh	$10.60	−$26.1K	889,436
2024-02-13	ARQTArcutis Biotherapeutics, Inc.A Award	Director, See Remarks	AAward	+21.7K sh	—	—	648,685
2024-02-13	ARQTArcutis Biotherapeutics, Inc.A Award	Director, See Remarks	AAward	+33.1K sh	—	—	681,751
2024-02-13	ARQTArcutis Biotherapeutics, Inc.A Award	Director, See Remarks	AAward	+94.1K sh	—	—	775,801
2024-02-13	ARQTArcutis Biotherapeutics, Inc.A Award	Director, See Remarks	AAward	+116K sh	—	—	891,901
2024-02-13	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−65K sh	—	—	0
2024-02-13	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−99.2K sh	—	—	0
2024-02-13	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−188K sh	—	—	0
2024-02-13	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−232K sh	—	—	0
2024-01-12	ARQTArcutis Biotherapeutics, Inc.A Award	Director, See Remarks	AAward	+125K sh	—	—	627,019
2024-01-12	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+410K sh	—	—	410,000
2023-12-20	ARQTArcutis Biotherapeutics, Inc.G Gift	Director, See Remarks	GGift	−6,563 sh	—	—	508,582

Recent filings

Accepted (ET)
Aug 54
Watanabe Todd0001628280-26-053753
SEC(opens sec.gov)
May 64
Watanabe Todd0001801061-26-000003
SEC(opens sec.gov)
Mar 34
Watanabe Todd0001628280-26-014327
SEC(opens sec.gov)
Feb 44
Watanabe Todd0001628280-26-005570
SEC(opens sec.gov)
Nov 244
Watanabe Todd0001801061-25-000012
SEC(opens sec.gov)
Nov 54
Watanabe Todd0001801061-25-000010
SEC(opens sec.gov)
Oct 304
Watanabe Todd0001801061-25-000008
SEC(opens sec.gov)
Oct 34
Watanabe Todd0001801061-25-000006
SEC(opens sec.gov)
Sep 104
Watanabe Todd0001787306-25-000136
SEC(opens sec.gov)
Aug 54
Watanabe Todd0001787306-25-000119
SEC(opens sec.gov)
Jun 124
Watanabe Todd Franklin0002065881-25-000013
SEC(opens sec.gov)

Companies

Arcutis Biotherapeutics, Inc.Director, See RemarksARQT

Address

C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300

WESTLAKE VILLAGE, CA, 91361